Population Pharmacokinetic Model of Plasma and Cellular Mycophenolic Acid in Kidney Transplant Patients from the CIMTRE Study-Reference-Cited by-同舟云学术

Population Pharmacokinetic Model of Plasma and Cellular Mycophenolic Acid in Kidney Transplant Patients from the CIMTRE Study

Published:2020-10-06 Issue:4 Volume:20 Page:331-342
ISSN:1174-5886
Container-title:Drugs in R&D
language:en
Short-container-title:Drugs R D

Author:

Riglet François^ORCID,Bertrand Julie,Barrail-Tran Aurélie,Verstuyft Céline,Michelon Hugues,Benech Henri,Durrbach Antoine,Furlan Valérie,Barau Caroline

Funder

Assistance Publique - Hôpitaux de Paris

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s40268-020-00319-y.pdf

Reference48 articles.

1. Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Barker C. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection: the International Mycophenolate Mofetil Renal Transplant Study Groups. Transplantation. 1997;63(1):39–47.

2. Brunet M, Cirera I, Martorell J, et al. Sequential determination of pharmacokinetics and pharmacodynamics of mycophenolic acid in liver transplant patients treated with mycophenolate mofetil. Transplantation. 2006;81(4):541–6. https://doi.org/10.1097/01.tp.0000200307.79962.48.

3. van Hest RM, Mathot RAA, Pescovitz MD, Gordon R, Mamelok RD, van Gelder T. Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients. J Am Soc Nephrol. 2006;17(3):871–80. https://doi.org/10.1681/ASN.2005101070.

4. Kiang TKL, Ensom MHH. Population pharmacokinetics of mycophenolic acid: an update. Clin Pharmacokinet. 2018;57(5):547–58. https://doi.org/10.1007/s40262-017-0593-6.

5. Bernard O, Guillemette C. The main role of UGT1A9 in the hepatic metabolism of mycophenolic acid and the effects of naturally occurring variants. Drug Metab Dispos Biol Fate Chem. 2004;32(8):775–8.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population pharmacokinetics of mycophenolate in patients treated for interstitial lung disease (EVER‐ILD study);Fundamental & Clinical Pharmacology;2024-06-16

2. Dynamic Monitoring of Intracellular Tacrolimus and Mycophenolic Acid Therapy in Renal Transplant Recipients Using Magnetic Bead Extraction Combined with LC-MS/MS;Pharmaceutics;2023-09-14

3. Significant Effects of Renal Function on Mycophenolic Acid Total Clearance in Pediatric Kidney Transplant Recipients with Population Pharmacokinetic Modeling;Clinical Pharmacokinetics;2023-07-26

4. Recent lessons learned from population pharmacokinetic studies of mycophenolic acid: physiological, genomic, and drug interactions leading to the prediction of drug effects;Expert Opinion on Drug Metabolism & Toxicology;2021-12-02

5. Model-informed precision dosing to optimise immunosuppressive therapy in renal transplantation;Drug Discovery Today;2021-11